The Harm Reduction International Conference, which is convened in a different city every two years, attracts over 1,000 international delegates and has been held in almost every region of the world. HR23 takes place in Melbourne, Australia, on 16-19 April 2023.

Returning to Australia for the first time in 19 years, the conference will be a unique opportunity showcase Melbourne’s incredible harm reduction programmes and the people who have made them possible, and also to push for further progress not just for the country, but for the region as a whole.

The conference theme, Strength in Solidarity, will underpin all HR23 activities and highlight the importance of our strength – as people, as a community, as a global movement – in sticking together.

The Public Health Institute Drug Related Deaths conference 2023 took place online Thursday 16th March 2023 via Microsoft Teams

The day was split into five sessions, with presentations and Q&A sessions from 14 great speakers.

Over 700 people attended online, a big thank you to everyone to attended, presented, and contributed during the day.

Links for PDF copies of presentations from the day are now available on the DRD conference page, as well as the recording from the morning sessions. There was some great discussion and networking taking place in the chat area, so we've also shared some resources mentioned during discussions too.

The very first Club Health conference was held in the world famous Cream nightclub, Liverpool in 1997. Following the success of the event, The 1st International Conference on Nightlife, Substance Use and Related Health Issues was held in Amsterdam in 1999. Club Health conferences have since been held bi-annually in Australia, North America and throughout Europe. The 12th International Club Health Conference on Nightlife, Substance Use and Related Health Issues returns to Liverpool in November 2023.

For more information about registration and abstracts please visit the conference website:

News & resource links

Needle and Syringe Provision: Minimum Standards Checklist

Minimum Standards for Needle Syringe Programme (NSP) Across Humankind. These minimum standards for used in conjunction with locally commissioned service level arrangements (e.g. for community pharmacy provision) documents where appropriate.

Posted: 28 Sept 2021

People who inject drugs: HIV and viral hepatitis monitoring

Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (PWID).

Posted: 28 July 2021

UK Drug strategy 2017

The drug strategy sets out how the government and its partners, at local, national and international levels, will take new action to tackle drug misuse and the harms it causes.

Posted: 14 July 2017

RSPH: Drug policy reform 'Taking a New Line on Drugs'

RSPH are calling for measures aimed at moving UK drugs strategy away from a predominantly criminal justice approach towards one based on public health and harm reduction. Their report 'Taking a New Line on Drugs' proposes a new approach to UK drug policy, featuring opinion from PHI director Jim McVeigh.

Posted: 16 June 2016

Guidance: Widening the availability of Naloxone

Naloxone is the emergency antidote for overdoses caused by heroin and other opiates/opioids (such as methadone and morphine). The main life-threatening effect of heroin and other opiates is to slow down and stop breathing. Naloxone blocks this effect and reverses the breathing difficulties. On the 1 October 2015, new regulations came into force, which allows for widening of the availability of naloxone.

Posted: 10 November 2015

NICE issues quality standards to encourage health living & reduce harm

The National Institute for Health and Care Excellence (NICE) has issued three new quality standards (QS82, QS83 & QS84) to encourage healthy living and reduce harm from smoking, alcohol and physical inactivity.

Posted: March 2015

PHE briefing: Foil provision

PHE briefing regarding legal changes allowing the provision of foil by drug treatment and needle syringe exchange providers.

Posted: August 2014

NICE guidance update: Needle and Syringe Exchange programmes

NICE public health guidance update(PH52) containing recommendations on needle and syringe programmes

Posted: April 2014

NTA Guide: Pharmacy services for drug users

Best practice guidance from the National Treatment Agency (NTA) for commissioners and providers of pharmaceutical services for drug users.

Posted: February 2006